Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Pharmacological Research|July 24, 2021
Anti-diabetic drugs and weight loss in patients with type 2 diabetesElisa Lazzaroni, Moufida Ben Nasr, Cristian Loretelli, et al.Frontiers in Endocrinology|May 2, 2022
Hybrid Close-Loop Systems Versus Predictive Low-Glucose Suspend and Sensor-Augmented Pump Therapy in Patients With Type 1 Diabetes: A Single-Center Cohort StudyMaria Elena Lunati, Paola Silvia Morpurgo, Antonio Rossi, et al.Diabetes/Metabolism Research and Reviews|July 13, 2022
Inflammation and vascular dysfunction: The negative synergistic combination of diabetes and COVID-19Andrea Mario Bolla, Cristian Loretelli, Laura Montefusco, et al.Pharmacological Research|February 26, 2023
eATP and autoimmune diabetesCristian Loretelli, Ida Pastore, Maria Elena Lunati, et al.Pharmacological Research|June 23, 2022
The anti-inflammatory and immunological properties of GLP-1 Receptor AgonistsGiulia Bendotti, Laura Montefusco, Maria Elena Lunati, et al.Journal of the Endocrine Society|January 19, 2026
A Randomized Study of the Glunovo Real-time CGM Effectiveness in Individuals With Poorly Controlled Type 2 DiabetesElisa Lazzaroni, Vincenzo Cimino, Alessandra Gandolfi, et al.Pharmacological Research|March 5, 2023
Broadening horizons in mechanisms, management, and treatment of diabetic kidney diseaseAdriana Petrazzuolo, Gianmarco Sabiu, Emma Assi, et al.The Journal of Clinical Endocrinology and Metabolism|February 23, 2026
The use of semaglutide as an add-on therapy in patients with LADAMaria Elena Lunati, Vincenzo Cimino, Davide Bernasconi, et al.Pharmacological Research|August 15, 2022
SGLT2-inhibitors are effective and safe in the elderly: The SOLD studyMaria Elena Lunati, Vincenzo Cimino, Alessandra Gandolfi, et al.Diabetes|August 25, 2023
Reversal of Experimental Autoimmune Diabetes With an sCD39/Anti-CD3 TreatmentCarmen Fotino, R Damaris Molano, Moufida Ben Nasr, et al.Pageof 5